HNF1A-MODY is associated with an intact CRP response during human endotoxaemia

HNF1A-MODY is associated with an intact CRP response during human endotoxaemia

Dettagli Bibliografici
Autori principali:	Mughal, SA, Beatty, S, Chai, J, Shah, N, Smith, D, James, T, Digby, J, McCarthy, M, Owen, K
Natura:	Journal article
Pubblicazione:	2014

Documenti analoghi

No attenuation of CRP response to acute inflammation is seen in HNF1A-MODY
di: Owen, K, et al.
Pubblicazione: (2013)

High-sensitivity CRP discriminates HNF1A-MODY from other subtypes of diabetes.
di: McDonald, T, et al.
Pubblicazione: (2011)

High-sensitivity CRP discriminates HNF1A-MODY from other subtypes of diabetes.
di: McDonald, T, et al.
Pubblicazione: (2011)

Altered cortisol metabolism in individuals with HNF1A-MODY
di: Juszczak, A, et al.
Pubblicazione: (2020)

Apolipoprotein M can discriminate HNF1A-MODY from Type 1 diabetes.
di: Mughal, SA, et al.
Pubblicazione: (2013)

Lipoprotein composition in HNF1A-MODY: differentiating between HNF1A-MODY and type 2 diabetes.
di: McDonald, T, et al.
Pubblicazione: (2012)

Response to Comment on: McDonald et al. High-Sensitivity CRP Discriminates HNF1A-MODY From Other Subtypes of Diabetes. Diabetes Care 2011;34:1860-1862.
di: McDonald, T, et al.
Pubblicazione: (2011)

Therapeutic regimens of endotoxaemia in sheep
di: A. Chalmeh
Pubblicazione: (2022-12-01)

Cystatin C is not a good candidate biomarker for HNF1A-MODY.
di: Nowak, N, et al.
Pubblicazione: (2013)

Cystatin C is not a good candidate biomarker for HNF1A-MODY
di: Nowak, N, et al.
Pubblicazione: (2013)

Evaluation of high sensitivity C-reactive protein as a screening tool for detecting young South Asians with maturity-onset diabetes of the young due to HNF1A mutations
di: Mughal, SA, et al.
Pubblicazione: (2013)

Keeping diabetes in the family: Lessons from a family with HNF-1α MODY
di: Selwood, M, et al.
Pubblicazione: (2008)

Endotoxaemia in haemodialysis: a novel factor in erythropoetin resistance?
di: Laura E A Harrison, et al.
Pubblicazione: (2012-01-01)

An Atypical HNF4A Mutation Which Does Not Conform to the Classic Presentation of HNF4A-MODY
di: Andrew J. Spiro, et al.
Pubblicazione: (2018-01-01)

Plasma fucosylated glycans and C-reactive protein as biomarkers of HNF1A-MODY in young adult–onset nonautoimmune diabetes
di: Juszczak, A, et al.
Pubblicazione: (2018)

Lipid profile indices in young people with GCK-MODY and HNF1A-MODY
di: Alla K. Ovsyannikova, et al.
Pubblicazione: (2022-01-01)

Variants influencing age at diagnosis of HNF1A-MODY
di: Agnieszka H. Ludwig-Słomczyńska, et al.
Pubblicazione: (2022-09-01)

Induced normothermia ameliorates the procoagulant host response in human endotoxaemia
di: Harmon, MBA, et al.
Pubblicazione: (2021)

The impact of metabolic endotoxaemia on the browning process in human adipocytes
di: Farah Omran, et al.
Pubblicazione: (2023-04-01)

Use of high sensitivity C-reactive protein and DG9-glycan index for differential diagnosis of maturity-onset diabetes of the young due to HNF1A mutations in young adults
di: Mughal, SA, et al.
Pubblicazione: (2013)

Hnf1alpha (MODY3) controls tissue-specific transcriptional programs and exerts opposed effects on cell growth in pancreatic islets and liver.
di: Servitja, J, et al.
Pubblicazione: (2009)

Efficacy of metformin versus sulfonylurea derivative in HNF4A-MODY
di: Nicole Oosterom, et al.
Pubblicazione: (2022-01-01)

Circulating CD36 is reduced in HNF1A-MODY carriers.
di: Siobhan Bacon, et al.
Pubblicazione: (2013-01-01)

Early Onset of Mody5 Due to Haploinsufficiency of HNF1B
di: Carmen Bustamante, MD, et al.
Pubblicazione: (2020-09-01)

Beta-glucans in advanced CKD: role in endotoxaemia and inflammation
di: Jonathan Wong, et al.
Pubblicazione: (2020-04-01)

Identification and assessment of glycan profiles as a biomarker for maturity onset diabetes of the young (MODY) due to hepatocyte nuclear factor 1 alpha (HNF1A) mutations
di: Gloyn, A, et al.
Pubblicazione: (2011)

Granuloma annulare and necrobiosis lipoidica in a patient with HNF1A-MODY
di: Gabriela Irene Garcia Brandes, et al.
Pubblicazione: (2022-05-01)

Description of clinical cases of the familial form of diabetes mellitus HNF1A-MODY
di: A. A. Baranova, et al.
Pubblicazione: (2021-06-01)

Incidence of HNF1A and GCK MODY Variants in a South African Population
di: Matsha TE, et al.
Pubblicazione: (2020-12-01)

Effects of endotoxaemia on protein metabolism in rat fast-twitch skeletal muscle and myocardium.
di: Andrew J Murton, et al.
Pubblicazione: (2009-09-01)

Pronounced inflammatory response to endotoxaemia during nighttime: a randomised cross-over trial.
di: Mahdi Alamili, et al.
Pubblicazione: (2014-01-01)

Possible in vivo tolerance of human polymorphonuclear neutrophil to low-grade exercise-induced endotoxaemia
di: G. Camus, et al.
Pubblicazione: (1998-01-01)

Semaglutide as a potential therapeutic alternative for HNF1B-MODY: a case study
di: Angham Almutair, et al.
Pubblicazione: (2024-03-01)

Severe preeclampsia and gene mutation HNF4A (MODY1): а case report
di: V. M. Gur'eva, et al.
Pubblicazione: (2018-08-01)

Effects of chronic endotoxaemia on oxygen consumption at different ambient temperatures in the unanaesthetised rat.
di: Goran, M, et al.
Pubblicazione: (1988)

Role of brain‐derived neurotrophic factor in endotoxaemia‐induced acute lung injury
di: Jinye Shi, et al.
Pubblicazione: (2023-12-01)

RhoA/Rho-kinase and nitric oxide in vascular reactivity in rats with endotoxaemia.
di: Mei-Hui Liao, et al.
Pubblicazione: (2013-01-01)

Assessment of high-sensitivity C-reactive protein levels as diagnostic discriminator of maturity-onset diabetes of the young due to HNF1A mutations.
di: Owen, K, et al.
Pubblicazione: (2010)

Maturity onset diabetes of the young due to HNF1A variants in Croatia
di: Pavić, T, et al.
Pubblicazione: (2018)

Clinical Characteristics of Patients With HNF1-alpha MODY: A Literature Review and Retrospective Chart Review
di: Qinying Zhao, et al.
Pubblicazione: (2022-06-01)